α-Lipoic acid modulates extracellular matrix and angiogenesis gene expression in non-healing wounds treated with hyperbaric oxygen therapy

Molecular Medicine

Volumn 14, Issue 3-4, 2008, Pages 175-183

  Alleva, Renata ^a   Tomasetti, Marco ^b   Sartini, Davide ^b   Emanuelli, Monica ^b   Nasole, Emanuele ^d   Di Donato, Ferruccio ^c   Borghi, Battista ^a   Santarelli, Lory ^a   Neuzil, Jiri ^d,e  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c MPM   (Italy)

^d GRIFFITH UNIVERSITY   (Australia)

^e INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; MATRIX METALLOPROTEINASE; PLACEBO; THIOCTIC ACID;

AGED; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HUMAN; HYPERBARIC OXYGEN; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; WOUND HEALING;

AGED; AGED, 80 AND OVER; AUTOCRINE COMMUNICATION; DOUBLE-BLIND METHOD; EXTRACELLULAR MATRIX; FEEDBACK, BIOCHEMICAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; HYPERBARIC OXYGENATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASES; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLACEBOS; PLATELET-DERIVED GROWTH FACTOR; THIOCTIC ACID; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING; WOUNDS AND INJURIES;

EID: 41649116230     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2007-00095.Alleva     Document Type: Article

References (45)

1. Martin P. (1997) Wounds healing-aiming for perfect skin regeneration. Science. 276:75-81.
2. Singer AJ, Clark RA. (1999) Cutaneous wound healing. N. Engl. J. Med. 341:738-46.
3. Yager DR, Nwomeh BC. (1999) The proteolytic environment of chronic wounds. Wound Rep. Regen. 7:433-41.
4. Nagase H, Visse R, Murphy G. (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 69:562-73.
5. Visse R, Nagase H. (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92:827-39.
6. Madlener M, Parks WC, Wermer S. (1998) Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp. Cell Res. 242:201-10.
7. Mast BA, Schultz GS. (1996) Interactions of cytokines, growth factors, and proteases in acute and chronic wounds. Wound Repair Regen. 4:411-20.
8. Ciaravino ME, Friedell ML, Kommerlocher TC. (1996) Is hyperbaric oxygen a useful adjuvant in the management of problem lower extremity wounds? Ann. Vasc. Surg. 10:558-62.
9. Abidia A et al. (2003) Role of hyperbaric oxygen therapy in ischemic, diabetic, lower-extremity ulcers: double-blind randomized controlled trial. Eur. J. Vasc. Endovasc. Surg. 25:513-18.
10. La Van FB, Hunt TK. (1990) Oxygen and wound healing. Clin. Plast. Surg. 17:463-72.
11. Kinighton DR, Halliday B, Hunt TK. (1986) Oxygen as an antibiotic: a comparison of the effects of inspired oxygen concentration and antibiotic administration on in vivo bacterial clearance. Arch. Surg. 121:191-95.
12. Alleva R, Nasole E, Di Donato F, Borghi B, Neuzil J, Tomasetti M. (2005) α-Lipoic acid supplementation inhibits oxidative damage, accelerating chronic wound healing in patients undergoing hyperbaric oxygen therapy. Biochem. Biophys. Res. Commun. 333:404-10.
13. Manuel JA, Gawronska-Kozak B. (2006) Matrix metalloproteinase 9 (MMP-9) is upregulated during scarless wound healing in athymic nude mice. Matrix Biol. 25:505-14.
14. Hsu JY, McKeon R, Goussev S, Werb Z, Lee JU, Trivedi A, Noble-Haeusslein LJ. (2006) Matrix metalloproteinase-2 facilitates wound healing events that promote functional recovery after spinal cord injury. J. Neurosci. 26:9841-50.
15. Amstrong DG, Jude EB. (2002) The role of matrix metalloproteinases in wound healing. J. Am. Podiatr. Med. 92:12-8.
16. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert, H. (2002) Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia. 45:1011-6.
17. Singer A, Clark RA. (1999) Cutaneous wound healing. New Engl. J. Med. 341:738-46.
18. Papanas N, Maltezos E. (2007) The diabetic foot: established and emerging treatments. Acta Clin. Belg. 62:230-8.
19. McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall CM. (2002) Matrix metalloproteinases processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood. 100:1160-67.
20. Van Den Steen PE, Wuyts A, Husson SJ, Proost P, Van Damme J, Opdenakker G. (2003) Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur. J. Biochem. 270:3739-49.
21. Gillard JA, Reed MWR, Buttle D, Cross SS, Brown NJ. (2004) Matrix metalloproteinases activity and immunohistochemical profile of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 during human dermal wound healing. Wound Rep. Reg. 12:295-304.
22. Gailit J, Clark RAF. (1994) Wound repair in the context of extracellular matrix. Curr. Opin. Cell Biol. 6:717-25.
23. Engelhardt E, Toksoy A, Goebeler M, Debus S, Broecker EB, Gillitzer R. (1998) Chemokines IL8, GROα, MCP1, IP10 and Mi are sequentially and differentially expressed during phase-specific infiltration of leukocytes subsets in human wound healing. Am. J. Pathol. 153:1849-60.
24. Wetzler C, Kaempfer H, Stallmeyer B, Pfeilschifter J, Frank S. (2000) Large and sustained induction of chemokines during impaired wound healing in the genetically diabetic mouse: prolonged persistence of neutrophilis and macrophages during the late phase of repair. J. Invest. Dermatol. 115:245-53.
25. Michel G, Kemeny L, Peter RU, Beetz A, Ried C, Arenberger P, Ruzicka T. (1992) Interleukin-8 receptor-mediated chemotaxis of normal human epithelial cells. FEBS Lett. 305:241-43.
26. Rennekampff HO, Hansbrough JF, Kiessig V, Dore C, Sticherling M, Schroeder JM. (2000) Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J. Surg. Res. 93:41-54.
27. Baker EA, Leaper DJ. (2000) Proteinases, their inhibitors, and cytokine profiles in acute wound fluid. Wound Rep. Reg. 8:392-8.
28. Pakele R, Watanabe T, Benedict CR. (2002) Induction of endothelial cell proliferation by angiogenic factors released by activated monocytes. Cardiovasc. Radiat. Med. 3:95-101.
29. Pepper MS, Mandriota SJ, Jeltsch M, Kumar V, Alitalo K. (1998) Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity. J. Cell Physiol. 177:439-52.
30. Lauer G et al. (2000) Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J. Invest. Dermatol. 115:12-8.
31. Detmar M et al. (1995) Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. J. Invest. Dermatol. 105:44-50.
32. Frank S, Hubner G, Breier G, Longaker MT, Greenhalgh DG, Werner S. (1995) Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J. Biol. Chem. 270:12607-13.
33. Detmar M, Brown LF, Berse B, Jackman RW, Elicker BM, Dvorak HF, Claffey KP. (1997) Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J. Invest. Dermatol. 108:263-8.
34. Al-Waili NS, Butler GJ. (2006) Effects of hyperbaric oxygen on inflammatory response to wound and trauma: possible mechanism of action. Sci. World J. 6:425-41.
35. Sheikh AY, Gibson JJ, Rollins MD, Hopf HW, Hussain Z, Hunt TK. (2000) Effect of hyperoxia on vascular endothelial growth factor levels in a wound model. Arch. Surg. 135:1293-7.
36. Asano T, Kaneko E, Shinozaki S, Imai Y, Shibayama M, Chiba T, Ai M, et al. (2007) Hyperbaric oxygen induces basic fibroblast growth factor and hepatocyte growth factor expression, and enhances blood perfusion and muscle regeneration in mouse ischemic hind limbs. Circ. J. 71:405-11.
37. Keyt BA, Barleau LT, Nguyen HV, Chen H, Heinsoh H, Vandlen R, Ferrara N. (1996) The carboxyl-terminal domain (111-165) of VEGF is crucial for its mitogenic potency. J. Biol. Chem. 271:7788-95.
38. Artwohl M et al. (2007) R-(+)-α-lipoic acid inhibits endothelial cell apoptosis and proliferation: involvement of Akt and retinoblastoma protein/ E2F-1. Am. J. Physiol. 293:E681-9.
39. Hye-Soon K et al. (2007) α-Lipoic acid inhibits matrix metalloproteinase-9 expression by inhibiting NF-κB transcriptional activity. Exp. Mol. Med. 39:106-13.
40. Karin M, Greten FR. (2005) NF-κB: Linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5:749-59.
41. Shure D, Senior RM, Griffin GL, Deuel TF. (1992) PDGF AA homodimmers are potent chemoattractants for fibroblasts and neutrophils, and for monocytes activated by lymphocytes or cytokines. Biochem. Biophys. Res. Commun. 186:1519-24.
42. Greenhalgh DG, Sprugel KH, Murray MJ, Ross R. (1990) PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am. J. Pathol. 136:1235-46.
43. Tsuboi R, Rifkin DB. (1990) Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/cb mice. J. Exp. Med. 172:245-51.
44. Pierce GF, Tarpley D, Yanagihara TA, Mustoe GM, Thomason A. (1992) PDGF-BB, TGF-β1, and basic FGF in dermal wound healing: neovessel and matrix formation and cessation of repair. Am. J. Pathol. 140:1375-88.
45. Crombleholme TM. (2000) Adenoviral-mediated gene transfer in wound healing. Wound Repair Regen. 8:460-72.